

Publisher: John Wiley & Sons Inc
E-ISSN: 1097-0045|78|4|266-277
ISSN: 0270-4137
Source: THE PROSTATE, Vol.78, Iss.4, 2018-03, pp. : 266-277
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Is angiogenesis still an attractive target in metastatic castration‐resistant prostate cancer?
BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. :


Methylselenocysteine preventing castration‐resistant progression of prostate cancer
THE PROSTATE, Vol. 75, Iss. 9, 2015-06 ,pp. :


Role of Immunotherapy in Castration‐Resistant Prostate Cancer (CRPC)
BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. :


The Role of Palliative Surgery in Castration-Resistant Prostate Cancer
Oncology Research and Treatment, Vol. 38, Iss. 12, 2015-0 ,pp. :